Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

Cirtran (CIRX) EPS (Weighted Average and Diluted) (2019 - 2025)

Cirtran filings provide 11 years of EPS (Weighted Average and Diluted) readings, the most recent being $0.12 for Q4 2025.

  • On a quarterly basis, EPS (Weighted Average and Diluted) rose 163.16% to $0.12 in Q4 2025 year-over-year; TTM through Dec 2025 was -$0.11, a 79.63% increase, with the full-year FY2025 number at -$0.11, up 79.25% from a year prior.
  • EPS (Weighted Average and Diluted) hit $0.12 in Q4 2025 for Cirtran, up from -$0.09 in the prior quarter.
  • In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $4.26 in Q4 2023 to a low of -$0.19 in Q4 2024.
  • Median EPS (Weighted Average and Diluted) over the past 5 years was -$0.06 (2022), compared with a mean of $0.21.
  • Biggest five-year swings in EPS (Weighted Average and Diluted): soared 5425.0% in 2023 and later plummeted 1206.89% in 2024.
  • Cirtran's EPS (Weighted Average and Diluted) stood at $0.01 in 2021, then crashed by 1169.15% to -$0.08 in 2022, then soared by 5425.0% to $4.26 in 2023, then tumbled by 104.46% to -$0.19 in 2024, then skyrocketed by 163.16% to $0.12 in 2025.
  • The last three reported values for EPS (Weighted Average and Diluted) were $0.12 (Q4 2025), -$0.09 (Q3 2025), and -$0.12 (Q2 2025) per Business Quant data.